Recombinant adeno-associated virus-mediated gene transfer of a soluble VEGFR3 decoy receptor showed the blockade of lymphatic metastasis in experimental models of prostate tumors and melanoma [19]. This evidence concerns the gene FLT4 and prostate neoplasm.